<DOC>
	<DOCNO>NCT02314351</DOCNO>
	<brief_summary>Migraine attack frequently diagnose emergency department . Also intravenous metoclopramide commonly use drug acute abortive treatment migraine . However , role metoclopramide base three randomize , placebo-controlled study , carry relatively patient . Those trial suggest metoclopramide produce large improvement visual analog scale ( VAS ) score , however reveal conflict result significant methodological problem ( risk bias , allocation concealment , intention-to-treat analysis ) . The investigator aim analyse effect intravenous metoclopramide acute migraine attack compare placebo .</brief_summary>
	<brief_title>Intravenous Metoclopramide Acute Treatment Migraine : A Double-blind , Randomized , Placebo-controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Presenting emergency department migraine attack ( aura without aura , accord International Headache Society criterion , 2013 ) The patient older 18 year Patients agree participate study read sign informed consent document The patient young 18 year Pregnants Patients take analgesic drug last 2 hour Documented declare allergy metoclopramide Patients hemodynamically unstable Patients agree participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>migraine disorder</keyword>
	<keyword>migraine aura</keyword>
	<keyword>migraine without aura</keyword>
	<keyword>pain management</keyword>
	<keyword>emergency department</keyword>
</DOC>